MINAPHARM Pharmaceuticals Balance Sheet Health
Financial Health criteria checks 2/6
MINAPHARM Pharmaceuticals has a total shareholder equity of EGP4.2B and total debt of EGP5.0B, which brings its debt-to-equity ratio to 119.6%. Its total assets and total liabilities are EGP11.1B and EGP6.9B respectively. MINAPHARM Pharmaceuticals's EBIT is EGP277.6M making its interest coverage ratio 0.9. It has cash and short-term investments of EGP3.3B.
Key information
119.6%
Debt to equity ratio
ج.م5.01b
Debt
Interest coverage ratio | 0.9x |
Cash | ج.م3.30b |
Equity | ج.م4.19b |
Total liabilities | ج.م6.92b |
Total assets | ج.م11.11b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: MIPH's short term assets (EGP5.5B) exceed its short term liabilities (EGP4.4B).
Long Term Liabilities: MIPH's short term assets (EGP5.5B) exceed its long term liabilities (EGP2.5B).
Debt to Equity History and Analysis
Debt Level: MIPH's net debt to equity ratio (40.7%) is considered high.
Reducing Debt: MIPH's debt to equity ratio has increased from 60.3% to 119.6% over the past 5 years.
Debt Coverage: MIPH's debt is not well covered by operating cash flow (2%).
Interest Coverage: MIPH's interest payments on its debt are not well covered by EBIT (0.9x coverage).